Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2018

May 16, 2018

284_dirs_2018-05-16_b17d16ab-4f43-40fd-b9b7-38d14a13fd10.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-05-15

Reporting Person: Gerberding Julie L. (EVP Strat Comm, Gl Pub Policy)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-05-15 Common Stock S 9972.0000 $59.6634 Disposed 45716.5270 Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.4500 to $59.7400, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

F2: Holdings include shares acquired in dividend reinvestment transactions.